<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR8">
 <label>8.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shitara</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Chin</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Yoshikawa</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Katai</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Terashima</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Ito</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Hirao</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Yoshida</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Oki</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Sasako</surname>
    <given-names>M</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy</article-title>
  <source>Gastric Cancer</source>
  <year>2017</year>
  <volume>20</volume>
  <issue>1</issue>
  <fpage>175</fpage>
  <lpage>181</lpage>
  <pub-id pub-id-type="doi">10.1007/s10120-015-0581-1</pub-id>
  <pub-id pub-id-type="pmid">26626800</pub-id>
 </element-citation>
</ref>
